Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact
Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: AKR1A1

Gene summary for AKR1A1

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

AKR1A1

Gene ID

10327

Gene namealdo-keto reductase family 1 member A1
Gene AliasALDR1
Cytomap1p34.1
Gene Typeprotein-coding
GO ID

GO:0005975

UniProtAcc

P14550


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
10327AKR1A1HTA11_3410_2000001011HumanColorectumAD1.74e-043.03e-010.0155
10327AKR1A1HTA11_2487_2000001011HumanColorectumSER3.80e-127.95e-01-0.1808
10327AKR1A1HTA11_1938_2000001011HumanColorectumAD2.71e-086.59e-01-0.0811
10327AKR1A1HTA11_78_2000001011HumanColorectumAD3.62e-105.87e-01-0.1088
10327AKR1A1HTA11_347_2000001011HumanColorectumAD3.75e-257.72e-01-0.1954
10327AKR1A1HTA11_411_2000001011HumanColorectumSER9.27e-071.08e+00-0.2602
10327AKR1A1HTA11_2112_2000001011HumanColorectumSER4.64e-027.11e-01-0.2196
10327AKR1A1HTA11_3361_2000001011HumanColorectumAD6.09e-065.16e-01-0.1207
10327AKR1A1HTA11_83_2000001011HumanColorectumSER3.78e-045.00e-01-0.1526
10327AKR1A1HTA11_696_2000001011HumanColorectumAD7.06e-329.37e-01-0.1464
10327AKR1A1HTA11_866_2000001011HumanColorectumAD2.60e-074.27e-01-0.1001
10327AKR1A1HTA11_1391_2000001011HumanColorectumAD6.15e-199.36e-01-0.059
10327AKR1A1HTA11_2992_2000001011HumanColorectumSER4.45e-067.77e-01-0.1706
10327AKR1A1HTA11_5216_2000001011HumanColorectumSER1.43e-026.40e-01-0.1462
10327AKR1A1HTA11_546_2000001011HumanColorectumAD1.26e-097.45e-01-0.0842
10327AKR1A1HTA11_7862_2000001011HumanColorectumAD1.22e-035.12e-01-0.0179
10327AKR1A1HTA11_866_3004761011HumanColorectumAD1.59e-196.16e-010.096
10327AKR1A1HTA11_8622_2000001021HumanColorectumSER4.56e-046.80e-010.0528
10327AKR1A1HTA11_7663_2000001011HumanColorectumSER1.42e-079.50e-010.0131
10327AKR1A1HTA11_10711_2000001011HumanColorectumAD1.76e-076.15e-010.0338
Page: 1 2 3 4 5 6 7 8 9 10 11 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
EndometriumThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AEH: Atypical endometrial hyperplasia
EEC: Endometrioid Cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
GCThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.CAG: Chronic atrophic gastritis
CAG with IM: Chronic atrophic gastritis with intestinal metaplasia
CSG: Chronic superficial gastritis
GC: Gastric cancer
SIM: Severe intestinal metaplasia
WIM: Wild intestinal metaplasia
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
ProstateThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.BPH: Benign Prostatic Hyperplasia
SkinThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AK: Actinic keratosis
cSCC: Cutaneous squamous cell carcinoma
SCCIS:squamous cell carcinoma in situ
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:0006091ColorectumADgeneration of precursor metabolites and energy209/3918490/187233.17e-286.61e-25209
GO:0022900ColorectumADelectron transport chain89/3918175/187231.42e-188.91e-1689
GO:0044282ColorectumADsmall molecule catabolic process118/3918376/187231.05e-063.55e-05118
GO:0009636ColorectumADresponse to toxic substance88/3918262/187231.12e-063.72e-0588
GO:0019318ColorectumADhexose metabolic process77/3918237/187231.96e-054.01e-0477
GO:0006066ColorectumADalcohol metabolic process106/3918353/187233.02e-055.57e-04106
GO:0098754ColorectumADdetoxification53/3918152/187234.63e-057.98e-0453
GO:0006790ColorectumADsulfur compound metabolic process101/3918339/187236.46e-051.07e-03101
GO:0005996ColorectumADmonosaccharide metabolic process80/3918257/187237.31e-051.17e-0380
GO:0072329ColorectumADmonocarboxylic acid catabolic process44/3918122/187238.05e-051.28e-0344
GO:0097237ColorectumADcellular response to toxic substance44/3918124/187231.24e-041.80e-0344
GO:1990748ColorectumADcellular detoxification41/3918116/187232.29e-042.97e-0341
GO:0006006ColorectumADglucose metabolic process62/3918196/187232.76e-043.39e-0362
GO:0016054ColorectumADorganic acid catabolic process73/3918240/187233.20e-043.81e-0373
GO:0046395ColorectumADcarboxylic acid catabolic process70/3918236/187239.06e-048.71e-0370
GO:0034308ColorectumADprimary alcohol metabolic process35/3918102/187231.16e-031.05e-0235
GO:0006081ColorectumADcellular aldehyde metabolic process22/391860/187233.64e-032.60e-0222
GO:00060911ColorectumSERgeneration of precursor metabolites and energy168/2897490/187231.39e-251.70e-22168
GO:00229001ColorectumSERelectron transport chain77/2897175/187231.77e-191.36e-1677
GO:00096361ColorectumSERresponse to toxic substance71/2897262/187238.63e-074.07e-0571
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
hsa05208ColorectumADChemical carcinogenesis - reactive oxygen species126/2092223/84651.01e-241.68e-221.07e-22126
hsa00620ColorectumADPyruvate metabolism28/209247/84653.71e-075.41e-063.45e-0628
hsa00010ColorectumADGlycolysis / Gluconeogenesis34/209267/84653.63e-064.34e-052.77e-0534
hsa00561ColorectumADGlycerolipid metabolism24/209263/84651.25e-024.54e-022.90e-0224
hsa052081ColorectumADChemical carcinogenesis - reactive oxygen species126/2092223/84651.01e-241.68e-221.07e-22126
hsa006201ColorectumADPyruvate metabolism28/209247/84653.71e-075.41e-063.45e-0628
hsa000101ColorectumADGlycolysis / Gluconeogenesis34/209267/84653.63e-064.34e-052.77e-0534
hsa005611ColorectumADGlycerolipid metabolism24/209263/84651.25e-024.54e-022.90e-0224
hsa006202ColorectumSERPyruvate metabolism22/158047/84659.62e-061.33e-049.67e-0522
hsa000102ColorectumSERGlycolysis / Gluconeogenesis24/158067/84656.62e-045.36e-033.89e-0324
hsa006203ColorectumSERPyruvate metabolism22/158047/84659.62e-061.33e-049.67e-0522
hsa000103ColorectumSERGlycolysis / Gluconeogenesis24/158067/84656.62e-045.36e-033.89e-0324
hsa052084ColorectumMSSChemical carcinogenesis - reactive oxygen species118/1875223/84652.71e-244.54e-222.78e-22118
hsa006204ColorectumMSSPyruvate metabolism24/187547/84651.25e-051.35e-048.27e-0524
hsa000104ColorectumMSSGlycolysis / Gluconeogenesis28/187567/84652.36e-041.81e-031.11e-0328
hsa005612ColorectumMSSGlycerolipid metabolism23/187563/84656.55e-032.64e-021.62e-0223
hsa052085ColorectumMSSChemical carcinogenesis - reactive oxygen species118/1875223/84652.71e-244.54e-222.78e-22118
hsa006205ColorectumMSSPyruvate metabolism24/187547/84651.25e-051.35e-048.27e-0524
hsa000105ColorectumMSSGlycolysis / Gluconeogenesis28/187567/84652.36e-041.81e-031.11e-0328
hsa005613ColorectumMSSGlycerolipid metabolism23/187563/84656.55e-032.64e-021.62e-0223
Page: 1 2 3 4 5 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
AKR1A1M2MACCervixADJPRDX1,CAPG,TMEM176B, etc.2.00e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
AKR1A1MASTCervixADJPRDX1,CAPG,TMEM176B, etc.2.57e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
AKR1A1M2MACCervixHSIL_HPVPRDX1,CAPG,TMEM176B, etc.1.60e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
AKR1A1M2MACEndometriumADJCD81,PRDX1,CAPG, etc.2.90e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
AKR1A1M2MACEndometriumAEHCD81,PRDX1,CAPG, etc.2.73e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
AKR1A1M2MACEndometriumEECCD81,PRDX1,CAPG, etc.3.82e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
AKR1A1M2MACEndometriumHealthyCD81,PRDX1,CAPG, etc.4.34e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
AKR1A1cDCSkinADJPRDX1,HLA-DQB2,FCGBP, etc.5.26e-02The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
AKR1A1LCSkinADJPRDX1,HLA-DQB2,FCGBP, etc.4.18e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
AKR1A1M2MACSkinADJPRDX1,HLA-DQB2,FCGBP, etc.2.06e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 2 3 4 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
AKR1A1SNVMissense_Mutationnovelc.631N>Tp.Ser211Cysp.S211CP14550protein_codingdeleterious(0.05)probably_damaging(0.996)TCGA-S3-AA0Z-01Breastbreast invasive carcinomaFemale<65I/IIAncillaryneulastaCR
AKR1A1deletionFrame_Shift_Delnovelc.945delGp.His316IlefsTer24p.H316Ifs*24P14550protein_codingTCGA-D8-A27V-01Breastbreast invasive carcinomaFemale<65I/IIHormone TherapytamoxiphenSD
AKR1A1SNVMissense_Mutationrs767717870c.106G>Ap.Ala36Thrp.A36TP14550protein_codingdeleterious(0.01)probably_damaging(0.977)TCGA-DS-A1OB-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycarboplatinPD
AKR1A1SNVMissense_Mutationnovelc.733C>Gp.Pro245Alap.P245AP14550protein_codingtolerated(0.2)benign(0.232)TCGA-DS-A1OB-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycarboplatinPD
AKR1A1SNVMissense_Mutationc.147C>Gp.Ile49Metp.I49MP14550protein_codingtolerated(0.05)benign(0.011)TCGA-EK-A2RA-01Cervixcervical & endocervical cancerFemale>=65I/IIUnknownUnknownSD
AKR1A1SNVMissense_Mutationnovelc.107C>Tp.Ala36Valp.A36VP14550protein_codingdeleterious(0.01)probably_damaging(0.98)TCGA-AA-A00N-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownPD
AKR1A1SNVMissense_Mutationnovelc.125N>Ap.Arg42Hisp.R42HP14550protein_codingdeleterious(0.01)probably_damaging(0.997)TCGA-AJ-A3EL-01Endometriumuterine corpus endometrioid carcinomaFemale<65I/IIUnknownUnknownSD
AKR1A1SNVMissense_Mutationrs757813969c.950C>Tp.Pro317Leup.P317LP14550protein_codingdeleterious(0)probably_damaging(0.989)TCGA-AP-A051-01Endometriumuterine corpus endometrioid carcinomaFemale>=65I/IIUnknownUnknownSD
AKR1A1SNVMissense_Mutationnovelc.8N>Ap.Ala3Aspp.A3DP14550protein_codingdeleterious(0)benign(0.034)TCGA-AP-A059-01Endometriumuterine corpus endometrioid carcinomaFemale>=65I/IIUnknownUnknownSD
AKR1A1SNVMissense_Mutationnovelc.825N>Tp.Lys275Asnp.K275NP14550protein_codingtolerated(0.27)benign(0.001)TCGA-AP-A1DV-01Endometriumuterine corpus endometrioid carcinomaFemale<65I/IIUnknownUnknownSD
Page: 1 2 3 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
10327AKR1A1ENZYME, DRUGGABLE GENOMEdoxorubicinDOXORUBICIN21048526
Page: 1